Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagogastric Juction Cancer”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Looking for participantsNCT06783569
What this trial is testing

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsGastric CancerEsophagogastric Juction Cancer+1 more
JiaRay Group 94
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Large-scale testing (Phase 3)Looking for participantsNCT04821843
What this trial is testing

Neoadjuvant Treatment Modalities in Esophageal Cancer

Who this might be right for
Esophageal CancerChemotherapy EffectChemoradiation+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,000